) revealed that the company has completed the previously
announced acquisition of German surgical tools firm, Berchtold
Holding. The deal is valued at $172 million.
ENZYMOTEC LTD (ENZY): Free Stock Analysis
EDWARDS LIFESCI (EW): Free Stock Analysis
OWENS & MINOR (OMI): Free Stock Analysis
STRYKER CORP (SYK): Free Stock Analysis
To read this article on Zacks.com click here.
Berchtold, a privately-held business, is a provider of surgical
infrastructure equipment with operating facilities in Germany and
the U.S. Berchtold's product portfolio comprises surgical tables,
equipment booms, and surgical lighting systems committed towards
maximizing efficiency and safety in operating rooms and ICUs.
The Berchtold acquisition is expected to boost Stryker's fast
growing endoscopy division and operating room equipment product
portfolio by adding complementary solutions. The deal will allow
Stryker to strengthen its portfolio and broaden its hospital
The deal is expected to be neutral to Stryker's 2014 earnings per
share excluding acquisition, integration-related and intangible
In Feb, Stryker announced agreements to acquire Berchtold Holding
as well as U.S.-based developer of hip arthroscopy products,
Pivot Medical, Inc. The company has already closed the
acquisition of Pivot Medical in Mar.
Pivot, a privately held business, sells products for hip
arthroscopy with operating facilities in Sunnyvale, Calif. It
specializes in hip arthroscopy procedures treating
femoroacetabular impingement syndrome (FAI). Pivot's platform of
instruments and implants provide efficient access to and restore
mobility of the hip with minimal incisions.
Pivot's offerings are expected to complement Stryker's existing
Sports Medicine portfolio and will provide Stryker's customers
with more comprehensive solutions to address certain challenges
faced during current Sports Medicine procedures. However, the
deal is expected to be neutral to Stryker's 2014 earnings per
share, excluding acquisition, integration-related and intangible
In Jan this year, Stryker also announced that it will buy Irvine,
CA-based Patient Safety Technologies for $120 million in order to
utilize Patient Safety's device to lessen the risk of surgical
sponges being left in patients after surgery. Recently, the
company settled a lawsuit over the impending deal where it has
agreed to make additional disclosures to appease shareholders.
In Dec last year, Stryker completed its acquisition of MAKO
Surgical for $1.65 billion. The acquisition of MAKO allowed
Stryker to get hold of the latter's advanced robotic arm
technology known as Robotic Arm Interactive Orthopedic System, or
RIO. The technology helps orthopedic surgeons in performing knee
and hip joint replacement surgeries.
Stryker currently carries a Zacks Rank #3 (Hold). Some
better-ranked stocks in the medical products companies that
currently worth a look include
Edwards Lifesciences Corp.
Owens & Minor Inc.
). Enzymotec carries a Zacks Rank #1 (Strong Buy), while both
Edwards Lifesciences Corp. and Owens & Minor retain a Zacks
Rank #2 (Buy).